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Summary
A key strategy in microbial pathogenesis is the sub-
version of the ﬁrst line of cellular immune defences
presented by professional phagocytes. Entero-
pathogenic and enterohaemorrhagic Escherichia coli
(EPEC and EHEC respectively) remain extracellular
while colonizing the gut mucosa by attaching and
effacing mechanism. EPEC use the type three secre-
tion system effector protein EspF to prevent their
own uptake into macrophages. EPEC can also block
in trans the internalization of IgG-opsonized par-
ticles. In this study, we show that EspJ is the
type three secretion system effector protein respon-
sible for trans-inhibition of macrophage opsono-
phagocytosis by both EPEC and EHEC. While
EspF plays no role in trans-inhibition of opsono-
phagocytosis, espJ mutants of EPEC or EHEC are
unable to block uptake of opsonized sheep red
blood cells (RBC), a phenotype that is rescued upon
complementation with the espJ gene. Importantly,
ectopic expression of EspJEHEC in phagocytes is suf-
ﬁcient to inhibit internalization of both IgG- and
C3bi-opsonized RBC. These results suggest that
EspJ targets a basic mechanism common to these
two unrelated phagocytic receptors. Moreover,
EspF and EspJ target independent aspects of the
phagocytic function of mammalian macrophages
in vitro.
Introduction
Enteropathogenic and enterohaemorrhagic Escherichia
coli (EPEC and EHEC respectively) belong to a family of
medically important diarrhoeagenic pathogens, which
colonize the gut mucosa by the attaching and effacing
(A/E) mechanism (for review, see Kaper et al., 2004). The
genes responsible for the A/E phenotype are carried on
the locus of enterocyte effacement (LEE) pathogenicity
island (McDaniel et al., 1995), which encodes transcrip-
tional regulators, the adhesin intimin (Jerse et al., 1990),
structural components of a type three secretion system
(T3SS) (Jarvis et al., 1995), chaperones, as well as trans-
locator and effector proteins (reviewed in Garmendia
et al., 2005). A/E lesions are characterized by localized
destruction of the brush border microvilli and intimate
attachment of the bacteria to the apical membrane of
enterocytes (Knutton et al., 1987).
EPEC and EHEC use the T3SS to inject into mamma-
lian host cells dozens of effector proteins (Garmendia
et al., 2005; Spears et al., 2006; Tobe et al., 2006), which
target different subcellular compartments and affect
diverse signalling pathways and physiological processes.
Among the effector proteins are EspI/NleA which is tar-
geted to the Golgi apparatus (Gruenheid et al., 2004;
Mundy et al., 2004), EspG and EspG2 which disrupt the
microtubule network (Matsuzawa et al., 2004; Hardwidge
et al., 2005; Shaw et al., 2005a; Tomson et al., 2005);
EspF which is targeted to the mitochondria and involved
in disruption of the tight junction barrier, elongation of
the intestinal brush border microvilli and cell death
(Crane et al., 2001; McNamara et al., 2001; Nougayrède
and Donnenberg, 2004; Nagai et al., 2005; Shaw et al.,
2005b); Map which induces ﬁlopodia formation (Kenny
et al., 2002); and Tir which downregulates Map-induced
signals (Kenny et al., 2002) and is involved in extensive
remodelling of the intermediate ﬁlament and the actin
microﬁlament networks (Kenny et al., 1997; reviewed in
Caron et al., 2006).
Avoidance of phagocytosis and the undermining of
macrophage signalling are common strategies used by
pathogenic bacteria to colonize the host while evading
immune defences (Coombes et al., 2004). Phagocytosis
is the process by which macrophage, neutrophils and
dendritic cells internalize particulate material over 0.5 mm
in diameter. Phagocytic uptake is a multistep, zipper-like
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driven by a local remodelling of the actin cytoskeleton.
The two best-characterized phagocytic receptors, com-
plement receptor 3 (CR3) and Fc gamma receptors
(FcgR), bind to opsonins deposited onto their targets,
respectively, complement fragment C3bi and IgG. These
two receptors are thought to mediate most of the phago-
cytic events occurring during innate and adaptive immune
responses. Despite a conservation in principles, the
mechanisms of internalization through CR3 and FcgR are
known to involve different mechanisms and signalling
pathways (Allen and Aderem, 1996; Caron and Hall,
1998).
EPEC and EHEC colonize the gut epithelium while
remaining extracellular. Interestingly, EPEC is able to
block its own uptake by professional phagocytes, a
process we refer to as cis-inhibition of phagocytosis
(Goosney et al., 1999; Celli et al., 2001; Quitard et al.,
2006). The mechanism involved depends on the T3SS
effector EspF but is poorly understood, although subver-
sion of a phosphatidyl inositol 3-kinase (PI3K)-controlled
pathway has been invoked (Celli et al., 2001; Quitard
et al., 2006). Importantly, EPEC were also reported
to inhibit in trans the phagocytosis of IgG-opsonized
zymosan particles via the FcgR upon infection of mac-
rophages (Celli et al., 2001), although the mechanism
involved is not known. The aim of this study was to inves-
tigate the basis for EPEC O127:H6 trans-antiphagocytic
activity and to determine if the same mechanism is shared
with EHEC O157:H7, which is the most common virulent
EHEC serotype.
Results
EPEC inhibit opsono-phagocytosis in a
T3SS-dependent mechanism
J774.A1 macrophages were infected for 1 h with wild-type
EPEC O127:H6 (strain E2348/69) and in parallel with
its isogenic T3SS-deﬁcient EPECDescN mutant (strain
ICC192) (Garmendia et al., 2004). Uninfected macroph-
ages were used as control. To maximize LEE gene
expression EPEC strains were primed for 3 h in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) prior to infec-
tion (Collington et al., 1998). In order to assist detection of
bacteria in infected macrophages, strains were trans-
formed with a GFP-expressing plasmid (pFVp25.1). After
infection, macrophages were washed then challenged
with sheep red blood cells (RBC) pre-opsonized with
either rabbit IgG or IgM and C5-deﬁcient serum, to direct
RBC for phagocytosis through FcgR and CR3 respectively
(Caron and Hall, 1998). Macrophages were then ﬁxed and
RBC differentially labelled pre- and post-permeabilization
in order to discriminate extracellular from phagocytosed
RBC. Infection of J774.A1 macrophages with wild-type
EPEC dramatically reduced uptake of both IgG- and C3bi-
opsonized RBC (Fig. 1). In contrast, infection with the
escN mutant resulted in phagocytosis of RBC at a com-
parable level to the non-infected control (Figs 1A and 3B).
Cos-7 cells transfected with phagocytic receptors
provide an alternative model to study opsono-
phagocytosis in isolation from macrophage receptors and
secreted products (Caron and Hall, 1998). In order to
conﬁrm the results observed in J774.A1, Cos-7 cells were
transfected with a construct encoding human FcgRIIA,
which confers strong IgG-dependent phagocytic ability;
then infected with EPEC strains and challenged with IgG-
opsonized RBC. Infection with wild-type EPEC abrogated
phagocytosis of opsonized RBC, as seen in J774.A1
macrophages. In contrast, when infected with EPEC-
DescN, efficient phagocytosis of RBC via the FcgRw a s
observed (Fig. 1B).
EspJ mediates EPEC trans-antiphagocytic activity
In order to identify the EPEC T3SS effector responsible
for the trans-inhibition of opsono-phagocytosis, we tested
a collection of T3SS effector mutants (listed in Table 1) for
their ability to inhibit FcgR-dependent phagocytosis. The
striking difference in RBC phagocytosis distinguishing
T3SS-competent (< 4% of the bound RBC are internal-
ized) and T3SS-deﬁcient (> 40% of the bound RBC are
internalized) strains allowed us to make a rapid visual
screen for mutants impaired in their ability to block FcgR-
mediated uptake (Fig. 2A and B). Phagocytosis protects
Fig. 1. EPEC inhibit FcgR-mediated phagocytosis in a
T3SS-dependent manner. J774.A1 macrophages (A) or
FcgR-transfected Cos cells (B) were left uninfected (control) or
infected with primed wild-type (wt) and DescN (escN) EPEC strains
for 1 h and then challenged with IgG-RBC for 30 min. Cells were
processed for immunoﬂuorescence and scored for phagocytic
index, i.e. the number of RBC bound to 100 cells. Values are
expressed relative to the non-infected control (none) values which
were set up at 100. Results are the mean  SD of two independent
experiments. Asterisks (*) denote a statistically signiﬁcant difference
with the wild-type strain.
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permeabilized cells, which makes them appear red under
the microscope (Fig. 2A). None of the 17 effector mutant
strains had any effect on the ability of IgG-opsonized RBC
to bind macrophages (Fig. 2B, bottom and data not
shown). The only mutant showing a signiﬁcantly greater
number of phagocytosed RBC than the parental strain
was EPECDespJ (strain ICC190) (Dahan et al., 2005).
Quantitative analysis revealed that infection of J774.A1
macrophages with EPECDespJ resulted in a level of RBC
phagocytosis equivalent to that seen in cells infected with
EPECDescN or in uninfected controls (Fig. 2B). To verify
the dependency of this inhibitory activity upon EspJ, we
complemented the espJ mutant strain ICC190 with a
plasmid encoding full-length EspJ (pICC32). Expression
of recombinant EspJ restored the ability of the DespJ
mutant to inhibit FcgR-dependent phagocytosis to a
similar level as wild-type EPEC (P > 0.05). These results
demonstrate that EspJ is the main T3SS effector involved
in the trans-inhibition of FcgR-mediated phagocytosis by
EPEC. Interestingly, although EspF has recently been
implicated in the inhibition of EPEC phagocytosis by
macrophages (Quitard et al., 2006), we detected no statis-
tically signiﬁcant difference in the uptake of IgG-opsonized
RBC by J774.A1 macrophages infected with either wild-
type EPEC or the isogenic EPECDespF mutant (Fig. 2B).
EspJ impairs CR3-mediated uptake
To study whether the antiphagocytic function of EPEC
EspJ is general or speciﬁc to the FcgR-dependent signal-
ling pathway, we examined the impact of EspJ on CR3-
mediated phagocytosis. Although phagocytosis mediated
by FcgR or CR3 is opsonin-dependent and actin-driven,
the signalling pathways responsible for actin polymeriza-
tion downstream of these two receptors are different
(Caron and Hall, 1998). J774.A1 macrophages were left
uninfected or infected with wild-type EPEC, EPECDescN,
EPECDespJ and EPECDespJ (pICC32) (complemented),
before challenge with C3bi-opsonized RBC. Wild-type
EPEC inhibited phagocytosis of C3bi-opsonized RBC in a
T3SS-dependent manner as no inhibition was seen after
infection with EPECDescN (Fig. 3B). Deletion of espJ also
impaired the ability of EPEC to block CR3-dependent
Table 1. Bacterial strains and plasmids used in this study.
Strains/plasmids Description Reference
Strains
85-170 EHEC O157:H7 spontaneous stx1- stx2-, Nal
R Stevens et al. (2004)
ICC217 DescN::Kn in 85-170, Kn
R This study
ICC188 DespJ::Kn in 85-170, Kn
R Dahan et al. (2005)
EDL933 EHEC O157:H7 stx- ATCC
ICC187 DescN::Kn in EHEC O157:H7 strain EDL933 Garmendia et al. (2004)
ICC184 DespF::Kn in EHEC O157:H7 strain EDL933 Garmendia et al. (2004)
E2348/69 EPEC O127:H6 Levine et al. (1978)
ICC192 DescN::Kn in E2348/69, Kn
R Garmendia et al. (2004)
ICC211 DespF::Kn in E2348/69, Kn
R Marchès et al. (2006)
ICC190 DespJ::Kn in E2348/69, Kn
R Dahan et al. (2005)
ICC193 DnleC::Kn in E2348/69, Kn
R Marchès et al. (2005)
ICC194 DnleD::Kn in E2348/69, Kn
R Marchès et al. (2005)
ICC225 Dtir::Kn in E2348/69, Kn
R This study
ICC257 Deae::Kn in E2348/69, Kn
R This study
ICC243 DespG1::Kn DespG2::Cm in E2348/69, Kn
R Cm
R This study
ICC202 Dmap::Kn in E2348/69, Kn
R Simpson et al. (2006)
ICC246 DespH::Kn in E2348/69, Kn
R This study
MK41 DsepZ::AphT3 in E2348/69, Kn
R Kanack et al. (2005)
ICC249 Dmap::Kn DespF::Cm in E2348/69, Kn
R Cm
R This study
ICC254 DnleH1::Kn DnleH2::Cm in E2348/69, Kn
R Cm
R This study
ICC248 DespI::Kn in E2348/69, Kn
R This study
ICC256 DnleI::Kn in E2348/69, Kn
R This study
ICC252 DnleF::Kn in E2348/69, Kn
R This study
ICC250 DnleB1::Cm in E2348/69, Cm
R This study
ICC251 DnleB2::Kn in E2348/69, Kn
R This study
Plasmid




pICC31 Derivative of pSA10 encoding EspJ
EHEC–FLAG fusion protein This study
pRK5-EspJ
EHEC–FLAG Derivative of pRK5 (BD Pharmingen) encoding EspJ
EHEC–FLAG fusion protein This study
pFPV25.1 Plasmid expressing gfpmut3a gene Valdivia and Falkow (1996)
pSB315 Source of aphT cassette Dahan et al. (2005)
pKD3 oriRg, blaM,C m
R cassette ﬂanked by FRT sites Datsenko and Wanner (2000)
pKD4 oriRg, blaM, Kan
R cassette ﬂanked by FRT sites Datsenko and Wanner (2000)
pKD46 ori101, repA 101 (ts), araBp-gam-bet-exo, blaM Datsenko and Wanner (2000)
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(Fig. 3A and B). Complementing the EPECDespJ mutant
restored the inhibition of C3bi-opsonized RBC uptake by
infected macrophages close to wild-type EPEC levels
(Fig. 3A and B). As seen for IgG-opsonized RBC,
pre-infection with EPEC strains had no impact on the
attachment of C3bi-opsonized RBC, suggesting that
translocated EspJ does not interfere with surface expres-
sion of the phagocytic receptors (FcgR and CR3 respec-
tively) but instead with a regulatory mechanism essential
for both CR3- and FcgR-dependent uptake. These results
show that EspJ inhibits opsono-phagocytosis via both the
CR3 and FcgR receptors.
EspJ from EHEC O157:H7 inhibits opsono-phagocytosis
Whether or not EHEC O157:H7 have antiphagocytic
activity is unknown. As espJ is conserved between EPEC
and EHEC (Dahan et al., 2005), we examined whether
EspJ mediates antiphagocytosis during EHEC infection of
J774.A1 macrophages. J774.A1 were infected with the
spontaneous stx minus EHEC O157:H7 strain 85-170 and
its isogenic mutants EHECDescN and EHECDespJ
(Table 1) before challenge with IgG- or C3bi-opsonized
RBC. As shown in Fig. 4A and B, both FcgR- and CR3-
dependent uptake of RBC were greatly diminished in
J774.A1 infected with the parental EHEC strain compared
with the levels of uptake observed in uninfected macro-
phages (control) or in cells infected with the EHECDescN
or EHECDespJ. Complementing the DespJ strain with a
plasmid encoding either EspJEPEC or EspJEHEC restored the
ability of the mutant strain to inhibit phagocytosis of IgG-
and C3bi-opsonized RBC (Fig. 4A and B). As for EPEC
(Fig. 3), impaired RBC phagocytosis was unrelated to
changes in RBC adhesion, which indicates that anti-
phagocytosis is due to impaired phagocytic signalling.
Fig. 2. EPEC inhibition of FcgR-mediated phagocytosis is EspF-independent but requires translocation of EspJ. J774.A1 macrophages
were left uninfected (control) or infected for 1 h with primed wild-type (wt), DescN (escN), DespF (espF), DespJ (espJ) and complemented
DespJ pICC32 (espJ pICC32) EPEC strains and then challenged with IgG-RBC for 30 min. Extracellular RBC were stained in green
using Alexa
TM488-conjugated anti-rabbit antibodies and, after permeabilization, all cell-associated RBC were stained in red using
rhodamine-conjugated anti-rabbit antibodies; cell nuclei were stained with DAPI. All bacteria are transformed with a GFP expressing plasmid.
A. Representative merged images of control cells or of macrophages infected with wild-type, DescN, DespF, DespJ, and complemented DespJ
pICC32 with bacteria in green (GFP), cell nuclei in blue, internalized RBC in red and extracellular RBC in yellow (merge of green and red
channels).
B. Quantiﬁcation of phagocytosis (deﬁned as percentage bound RBC that are internalized) and attachment index (deﬁned as the number of
RBC bound to 100 macrophages). Results are the mean  SD of three independent experiments. Asterisks (*) denote a statistically signiﬁcant
difference with the wild-type strain.
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bacterial phagocytosis
Several reports have involved EspF in bacterial-induced
inhibition of EPEC phagocytosis by M cells and cultured
macrophages (Quitard et al., 2006; Martinez-Argudo
et al., 2007), a ﬁnding we have conﬁrmed in this study
(data not shown). However, no data exist on the potential
inhibition of bacterial uptake by EHEC. To address this
question, J774.A1 macrophages were infected for 4 h
with wild-type, DescN, DespJ and DespF EHEC strains
and the attachment indices and percentage phagocytosis
were scored. As shown in Fig. 5, EHEC bacteria are able
to interfere with their own uptake in a T3SS-dependent
manner, as DescN bacteria were more readily phagocy-
tosed than the wild-type control. Importantly, DespF EHEC
behaved as the T3SS-deﬁcient DescN isogenic control,
showing that EspFEHEC, like EspFEPEC, controls cis-
inhibition of phagocytosis. In contrast, DespJ EHEC were
unimpaired in their ability to inhibit bacterial phagocytosis,
establishing that two distinct molecular mechanisms
control cis- and trans-inhibition of phagocytosis by EPEC
and EHEC.
EspJ expression is sufficient for antiphagocytosis in
transfected Cos-7 cells
Given the striking phenotype exhibited by espJ mutant
strains on the inhibition of FcgR- and CR3-dependent
phagocytic pathways, we examined if ectopic expression
of EspJ in phagocytes was sufficient to impair opsono-
Fig. 3. EPEC inhibition of CR3-mediated phagocytosis is EspJ dependent. J774.A1 macrophages were left uninfected (control) or infected for
1 h with primed wild-type (wt), DescN (escN), DespJ (espJ) and complemented DespJ pICC32 (espJ pICC32) EPEC strains, treated with
150 ng ml
-1 PMA to activate the C3bi binding site on CR3 receptors, then challenged with C3bi-opsonized RBC for 30 min. Extracellular RBC
were stained in green using Alexa
TM488-conjugated anti-rabbit antibodies and, after permeabilization, all cell-associated RBC were stained in
red using rhodamine-conjugated anti-rabbit antibodies; cell nuclei were stained with DAPI. All bacteria are transformed with a GFP-expressing
plasmid.
A. Representative merged images of control cells and of macrophages infected with wild-type, DescN, DespJ, and complemented DespJ
pICC32 with bacteria in green (GFP), cell nuclei in blue, internalized RBC in red and extracellular RBC in yellow (merge of green and red
channels).
B. Quantiﬁcation of phagocytosis (deﬁned as percentage bound RBC that are internalized) and attachment index (deﬁned as the number of
RBC bound to 100 macrophages). Results are the mean  SD of three independent experiments. Asterisks (*) denote a statistically signiﬁcant
difference with the wild-type strain.
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eukaryotic expression vector and co-transfected with the
FcgRIIA or CR3 phagocytic receptors. Cells were then
challenged with IgG- or C3bi-opsonized RBC and scored
for RBC binding and phagocytosis. EspJ expression had
no effect on the binding of C3bi- or IgG-opsonized RBC to
receptor transfected Cos-7 cells (data not shown). In con-
trast, a clear and statistically signiﬁcant inhibition of both
FcgR- and CR3-mediated uptake was observed in EspJ-
expressing Cos-7 cells (Fig. 6A and B), showing that the
expression of EspJ inside host cells is sufficient for inhi-
bition of opsono-phagocytosis.
The presence of a FLAG tag on EspJ allowed us to
examine the basic features of the inhibition in trans
of opsono-phagocytosis. Overexpressed EspJ was
excluded from the nucleus and localized throughout the
cytosol of Cos-7 cells, both in a diffuse fashion and in
large aggregates. RBC challenge of Cos-7 cells coex-
pressing FcgRIIA and EspJ did not affect the overall local-
ization of EspJ (Fig. 7 and data not shown). Interestingly,
ectopically expressed EspJ did not speciﬁcally accumu-
late to any signiﬁcant extent at the plasma membrane or
at sites of RBC attachment. Moreover, EspJ expression
did not prevent actin polymerization underneath bound
IgG-opsonized RBC (Fig. 7, top, arrowhead). Overall,
these data suggest that EspJ blocks FcgR-mediated
phagocytosis from a distance, rather than acting locally at
the nascent phagocytic cup, possibly by interfering with
the later stages of RBC uptake, after initial F-actin poly-
merization has taken place.
Discussion
In the past few years antiphagocytosis has been pro-
posed as a pathogenic mechanism for EPEC (Celli et al.,
2001). However the molecular basis of this phenomenon
is poorly understood. Antiphagocytic activity is clearly
dependent on the translocation of one or more effectors
through the EPEC T3SS into the cytosol of macrophage-
like cells and manifests itself both as an ability of EPEC to
reduce their own uptake (cis-inhibition) and to block
in trans the phagocytosis of IgG-opsonized zymosan par-
Fig. 4. EHEC inhibits opsono-phagocytosis through the translocated effector EspJ. J774.A1 macrophages were left uninfected (control) or
infected with EHEC wild-type (wt), DescN (escN), DespJ (espJ), or complemented DespJ pICC31 (espJ pICC31) for 4 h and then challenged
with IgG-opsonized RBC (A) or C3bi-opsonized RBC (B) for 30 min and processed for immunoﬂuorescence as described in Experimental
procedures. Quantiﬁcation of phagocytosis (deﬁned as percentage bound RBC that are internalized) and attachment index (deﬁned as the
number of RBC bound to 100 macrophages) for FcgR- (A) and CR3- (B) mediated phagocytosis are shown. Results are the mean  SD of
three independent experiments. Asterisks (*) denote a statistically signiﬁcant difference with the wild-type strain.
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1999; Celli et al., 2001). Whether these two phenotypes
correspond to a unique mechanism or reﬂects the exist-
ence of two independent antiphagocytic mechanisms was
unknown. Other bacterial pathogens are known to modu-
late phagocytosis, either – like Salmonella typhimurium
and Shigella ﬂexneri – by stimulating their uptake by non-
professional phagocytes or – like Yersinia and Clostridium
spp. – by blocking phagocytic signalling in phagocytic
cells. In all cases the underlying mechanisms involve the
subversion of actin dynamics (reviewed in Rottner et al.,
2005).
The mechanism by which EPEC block their own uptake
has been attributed to the effector EspF (Quitard et al.,
2006). We report in this article that EHEC O157:H7 also
block their own uptake by macrophages in an EspF-
dependent manner (Fig. 5), suggesting that antiphagocy-
tosis is a general mechanism displayed by both EHEC
and EPEC. In this report we demonstrate that (i) EHEC,
Fig. 5. EspF, but not EspJ, controls cis-inhibition of EHEC
phagocytosis in macrophages. J774.A1 macrophages were infected
for 4 h at 37°C with 1:100 dilutions of overnight cultures of
GFP-expressing EHEC O157:H7 strains as indicated and
processed for immunoﬂuorescence. Extracellular bacteria were
stained red, as described in Experimental procedures, and were
therefore easily distinguishable from internalized bacteria, which
are solely green. The percentage of bound EHEC internalized
(% phagocytosis) and the total number of cell-associated bacteria
(attachment index) were scored under the epiﬂuorescence
microscope. Results are expressed as mean  SD from three
independent experiments, with  100 macrophages scored per
condition per experiment. Asterisks (*) denote a statistically
signiﬁcant difference with the wild-type strain.
Fig. 7. Intracellular distribution of ectopically
expressed EspJ during FcgR-dependent
uptake. Cos-7 cells were co-transfected with
FcgRIIa and either with pRK5-EspJFLAG (top)
or with empty pRK5 (bottom) and challenged
with IgG-opsonized RBC for 30 min at 37°C,
as described in the legend to Fig. 5.
RBC-challenged cells were permeabilized and
stained with an anti-ﬂag mouse monoclonal
followed by Cy2-conjugated anti-mouse
antibodies (green), rhodamine phalloidin to
visualize F-actin (red) and Cy5-conjugated
anti-rabbit IgG-RBC (blue). Cells were
observed by confocal microscopy;
representative examples are shown.
Scale bar, 10 mm.
Fig. 6. Intracellular expression of EspJ is sufficient for inhibition of
FcgR- and CR3-mediated phagocytosis. Cos-7 cells were
co-transfected by nucleofection with FcgRIIA (A) or CR3 receptor
(B) and either with plasmid pRK5 or with pRK5-EspJ
overexpressing EspJ from EHEC and were then challenged for
30 min with IgG- (A) or C3bi- (B) opsonized RBC. RBC
phagocytosis was then quantiﬁed as described in Experimental
procedures, the transfected cells being easily distinguishable from
non-transfected cells by their unique ability to bind opsonized RBC.
Results are the mean  SD of at least two independent
experiments.
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particles, (ii) EPEC and EHEC trans-inhibition of phago-
cytosis is T3SS-dependent, and (iii) EspJ (EPEC and
EHEC) is the effector protein responsible for the inhibition
of both FcgR- and CR3-mediated phagocytosis, suggest-
ing that EspJ targets an essential host molecule or
complex normally involved downstream of these two
phagocytic receptors. Two clostridium toxins, the B toxins
from Clostridium difficile strains 10463 and 1470, inhibit
FcgR- and CR3-mediated phagocytosis (Caron and Hall,
1998; Caron et al., 2000). Both glucosylate and inactivate
members of the Rho family of small GTP-binding proteins,
known to regulate actin polymerization during a variety of
eukaryotic processes, including phagocytosis (Just et al.,
1995; Chaves-Olarte et al., 1999; Jaffe and Hall, 2005;
Niedergang and Chavrier, 2005). However, to our knowl-
edge, EspJ is the ﬁrst example of a type three secretion
effector that blocks both FcgR- and CR3-mediated
phagocytosis.
Our results show that, as has been shown for EPEC,
EHEC can inhibit opsono-phagocytosis. This may not be
surprising, as EHEC are thought to have evolved from
EPECthroughtheacquisitionofphagesencodingaShiga-
like toxin (Reid et al., 2000). It will be interesting to check
whether other strains able to induce A/E lesions can also
block phagocytosis. In order to ﬁnd the effector protein
conferring EPEC the ability to block phagocytosis in trans,
we screened 17 candidate effectors mutants we had accu-
mulated in the lab. Interestingly, neither EspF, involved in
inhibition of EPEC phagocytosis by macrophages and M
cells (Quitard et al., 2006; Martinez-Argudo et al., 2007);
Tir, involved in redistribution of intermediate ﬁlament pro-
teins and triggering of actin polymerization; Map, involved
in ﬁlopodia formation; or EspG/EspG2, involved in disrup-
tion of the microtubule network (reviewed in Garmendia
et al., 2005 and Caron et al., 2006) were involved. In
contrast, deletion of espJ, which is carried upstream of
tccP(Garmendiaet al.,2004)onprophageCP-933U/Sp14
in EHEC, abolished phagocytosis of opsonized RBC. The
phagocytosis defect was complemented by recombinant
espJ. Interestingly EspJ is dispensable for cis-inhibition of
EHEC or EPEC uptake (Fig. 5 and V. Covarelli, O.
Marchès, G. Frankel and E. Caron, unpubl. results).Taken
together our results show that inhibition of cis- and trans-
phagocytosis are mediated by different effectors and are
likely to involve different signalling pathways.
Sequence analysis reveals, as expected, that EspJEPEC
shows a very strong (79%) sequence identity at the amino
acid level with EspJEHEC and an open reading frame (75%
identity) in Citrobacter rodentium, the mouse A/E patho-
gen (Dahan et al., 2005). Interestingly, database searches
also show a 57% identity (74% similarity) with a putative
protein from Salmonella bongori. S. bongori mainly infects
cold-blooded animals but is also associated to rare cases
of acute enteritis in humans (Giammanco et al., 2002).
As S. bongori differs from Salmonella enterica by the
absence of the SPI-2 (Salmonella pathogenicity island
two), whose expression is induced intracellularly and
which is essential for intracellular survival and replication
within macrophages (Ochman and Groisman, 1996;
Waterman and Holden, 2003), it is tempting to speculate
that an antiphagocytic protein would allow S. bongori to
survive its interaction with phagocytic cells in its hosts.
Our study establishes that EspJ is necessary and suf-
ﬁcient to block uptake of C3bi- and IgG-opsonized RBC.
In a previous study EPEC were shown to be unable to
block uptake of C3bi-opsonized zymosan (Celli et al.,
2001). The reason for this discrepancy is unclear. While
zymosan and RBC are distinct phagocytic targets,
opsonization with IgG or C3bi fragments should ensure
that when opsonized the two types of particles interact
with identical surface receptors FcgR and CR3
respectively. The only other difference between the two
studies is the source of phagocytic cells [bone marrow
macrophage-derived cell line in Celli et al. (2001);
J774.A1 and transfected Cos-7 cells in this study].
Because we obtained similar results in a murine macroph-
age cell line and in Cos-7 cells transfected with either
FcgRIIA or CR3, and because EspJ expression is suffi-
cient to block phagocytosis, we strongly believe that EspJ
targets a critical regulatory pathway activated down-
stream of the two receptors; this pathway is furthermore
conserved both in macrophages and in Cos-7 cells.
What is the mechanism by which EspJ blocks FcgR-
and CR3-mediated opsono-phagocytosis of RBC? On the
one hand, bioinformatic searches on EspJ did not yield
any recognizable domain or sequence that could help us
clarify its function. On the other hand, phagocytosis
through these two receptors is ultrastructurally, pharma-
cologically and functionally different. In macrophages,
FcgR-mediated uptake is constitutive and pro-
inﬂammatory, involves the protrusion of actin-rich pseudo-
pods and is controlled by tyrosine kinases, Cdc42 and
Rac activity; in contrast, CR3-dependent internalization is
not accompanied by major protrusions or production of
pro-inﬂammatory signals, does not require tyrosine
kinase, Rac or Cdc42 activity but is dependent on RhoA
activity for actin polymerization at sites of particle binding
(Allen and Aderem, 1996; Caron and Hall, 1998; Nieder-
gang and Chavrier, 2005). Nonetheless, these two modes
of engulfment share two requirements: local actin poly-
merization and membrane delivery at sites of particle
binding (Allen and Aderem, 1996; Braun and Niedergang,
2006). We show that F-actin is still detected at sites of
RBC binding in EspJ-expressing cells, suggesting that
EspJ could interfere with the delivery of membrane at
nascent phagosomes. In line with this observation, EspJ
is found on intracellular structures, possibly endomem-
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not recruited to forming phagosomes. Phagocytosis is
known to involve the focal delivery of membrane from
various intracellular sources at sites of particle binding
(Gagnon et al., 2002; Braun et al., 2004). Identiﬁcation of
the putative EspJ-rich compartment would help us shed
light on the EspJ-dependent antiphagocytic mechanism,
which might involve the blocking either of membrane
per se or of some unknown membrane-borne regulator(s)
of uptake.
Current understanding of infections by A/E pathogens
points towards an extracellular lifestyle, with bacteria
adhering strongly to the surface of enterocytes. In EPEC
and EHEC, type three secretion, which controls formation
ofA/E lesions, is important for host colonization (reviewed
in Spears et al., 2006). It is now clear that the T3SS
also controls antiphagocytosis (Goosney et al., 1999;
Celli et al., 2001; this report). Importantly, ultrastructural
studies showed that EHEC O157:H7 colonize Peyer’s
patch mucosa ex vivo (Phillips et al., 2000), C. rodentium
ﬁrst targets the caecal patch in vivo (Wiles et al., 2004)
while RDEC-1 (rabbit EPEC) ﬁrst targets ileal M cells, an
intestinal phagocyte that binds but does not internalize
these bacteria, before spreading to other intestinal sites
(Inman and Cantey, 1983). It is conceivable that EspF-
mediated, cis-inhibition of phagocytosis (Quitard et al.,
2006; Martinez-Argudo et al., 2007) allowsA/E bacteria to
prevent their internalization early on during infection and
thereby facilitates colonization of the intestine. EspJ-
mediated trans-inhibition could be a mechanism to ensure
that bacteria-associated host cells are not internalized by
phagocytic cells that are recruited to the lumen of the gut
as a result of inﬂammation once colonization of the epi-
thelial is established (Inman and Cantey, 1983) or after an
adaptive immune response has been mounted. Further
studies are needed to unravel the molecular basis of EspJ
and EspF antiphagocytic activities and their respective
roles in colonization and infection.
Experimental procedures
Bacterial strains
The wild-type strains EPEC O127:H6 E2349/68 and EHEC
O157:H7 85-170 used in this study and their mutants are listed
in Table 1. Bacteria were grown in Luria–Bertani (LB) medium
or in DMEM supplemented with kanamycin (50 mgm l
-1), chlo-
ramphenicol (5 mgm l -1) and carbenicillin (100 mgm l -1), when
necessary. The mutant strains engineered during this study were
constructed using the PCR one-step l Red recombinase method
(Datsenko and Wanner, 2000). Brieﬂy, each mutation was
obtained using a PCR product containing an antibiotic resistance
gene ﬂanked by the 50 bases from the 5′ and 3′ ends of the target
gene. Plasmids pKD4, pKK3 and pSB315 were used as PCR
template. The PCR products were electroporated into the recipi-
ent strains carrying the Red system expression plasmid pKD46
and mutants were selected on LB plates with kanamycin or
chloramphenicol. Recombinant clones were cured of pKD46
plasmid by growth at the non-permissive temperature (42°C) and
mutation conﬁrmed by different PCR reactions using primers
ﬂanking the targeted region and primers into the antibiotic resis-
tance gene.
Cell culture and transfection
Cells from the murine macrophage J774.A1 and simian kidney
ﬁbroblast Cos-7 cell lines (ATCC) were maintained in DMEM
supplemented with 10% heat-inactivated fetal calf serum (FCS)
and penicillin/streptomycin. J774.A1 were seeded on glass cov-
erslips (13 mm diameter) in 24-well plates at a density of 5 ¥ 10
4
cells per well 24 h before infection. Cos-7 cells were seeded on
coverslips in 6 cm dishes (10
5 cells per dish) and transfected
either by nucleofection (Amaxa, Cologne, Germany) or using the
calcium/phosphate protocol (Cougoule et al., 2006). Brieﬂy, DNA/
calcium phosphate precipitates (10 mg of DNA/400 ml of calcium
phosphate/6 cm dishes containing 3.6 ml of fresh medium) were
added onto the cells for 16–18 h, washed and incubated in fresh
medium for an additional 6 h.
Plasmids
pICC32 and pICC31 are derivatives of pSA10 (Schlosser-
Silverman et al., 2000), a vector containing multiple cloning sites
downstream of the tac promoter. Pair of primers EspJf1
5′-CGGAATTCATGCCAATCATAAAGAACTGC-3′ and EspJr1
5′-AAAACTGCAGTTATTTATCATCATCATCTTTATAATCTTTTTT
GAGTGGGTGGATAT-3′ and pair of primers EspJf2 5′-CG
GAATTCATGTCAATTATAAAAAACTGCTTATC-3′ and EspJr2
5′-AAAACTGCAGTTATTTATCATCATCATCTTTATAATCTTTTTT
GAGAGGATATATGTCAAC-3′ were used to amplify espJ fused to
a FLAG tag from the wild-type EPEC and the wild-type EHEC
respectively. PCR products containing terminal EcoRI and PstI
restriction sites were digested and cloned into pSA10, generating
plasmids pICC32 and pICC31. Plasmid pRK5-EspJ
EHECFLAG
encoding EspJ from EHEC fused to a FLAG tag was obtained by
EcoRI and PstI digestion of the PCR fragment obtained with
primers EspJf2–EspJr2 and cloning into the eukaryotic expres-
sion vector pRK5 (BD Pharmingen).
Phagocytic assay and immunoﬂuorescence
Overnight EPEC cultures in LB were diluted 1:100 into DMEM
containing 25 mM Hepes and 2 mM Glutamax (Invitrogen) and
pre-activated by incubation for 3 h at 37°C in a 5% CO2 atmo-
sphere before infection. EHEC bacteria were grown overnight in
DMEM supplemented with 5% FCS and directly added onto
mammalian cells. J774.A1 or Cos-7 cells were incubated for at
least 1 h in serum-free medium then infected either for 1 h with
EPEC at a multiplicity of infection (moi) of 20:1 or for 4 h with
EHEC at a moi of 200:1, conditions that lead a similar average
number of bacteria (20–50) interacting with each macrophage at
the end of the infection period. Conditions for optimal induction of
LEE expression and optimal association with host cells have
been described previously (Garmendia et al., 2004; Quitard
et al., 2006).
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washed with PBS and challenged for 30 min at 37°C in 5% CO2
with 500 ml of IgG- or C3bi-opsonized sheep RBC (TCS) at a
ratio of 30 RBC per cell. RBC were opsonized as previously
described (Caron and Hall, 1998; Patel et al., 2002). Brieﬂy, for
FcgR-mediated phagocytosis, 0.5 ml of RBC per coverslip were
opsonized for 30 min with a subagglutinating concentration of
rabbit anti-RBC IgG (Cappel) in 1 ml of gelatin veronal buffer
(GVB
2+, Sigma), washed once with GVB2+ and re-suspended in
500 ml of DMEM/coverslip. For CR3-mediated phagocytosis,
0.5 ml of RBC per coverslip were opsonized with rabbit anti-
RBC IgM (Cedarlane Laboratories) for 30 min at room tempera-
ture in 1 ml of GVB
2+, pelleted, incubated for 20 min at 37°C
with C5-deﬁcient human serum (Sigma) and re-suspended in
500 ml of DMEM/coverslip. For efficient binding and phagocyto-
sis of C3bi-opsonized RBC, J774.A1 were pre-treated with
150 ng ml
-1 PMA in serum-free DMEM for 15 min before RBC
challenge. After phagocytic challenge, cells were washed twice
in PBS and ﬁxed for 20 min in 4% paraformaldehyde. Free
aldehyde groups were neutralized with 50 mM NH4Cl in PBS for
15 min and cells were blocked with 10% donkey serum in PBS
for 30 min. For differential staining of external and internalized
IgG- or C3bi-opsonized RBC, cells were incubated with
Alexa
TM488-conjugated donkey anti-rabbit antibodies, perme-
abilized with 0.5% Triton for 10 min and incubated with
Rhodamine-conjugated donkey anti-rabbit antibodies. Cover-
slips were mounted in Pro-Long antifade reagent (Invitrogen)
and analysed using a ZEISS Axioimager ﬂuorescence
microscope. Binding and phagocytosis indices were deter-
mined by counting the number of RBC, respectively,
associated to and internalized by a minimum of 50 cells,
be they J774A.1 macrophages, FcgR- or CR3-transfected
Cos-7 cells.
EHEC phagocytosis. EHEC bacterial strains expressing the
GFP-encoding pFPV25.1 plasmid were used (see Table 1). Over-
night cultures were diluted 1/100 in SFM supplemented with
25 mM Hepes and the appropriate antibiotic, then added onto
J774.A1 macrophages for 4 h at 37°C. Cells were ﬁxed and
incubated successively with goat anti-EHEC O157:H7 IgG
(Fitzgerald) then Texas red-conjugated donkey anti-goat IgG, to
stain extracellular EHEC in red. Cells were then permeabilized,
F-actin was labelled red, using Rhodamine RedX-coupled phal-
loidin (Molecular Probes), and coverslips were mounted on
Mowiol (Calbiochem). The numbers of bacteria bound (red) and
internalized (green) were scored using an epiﬂuorescence micro-
scope (BX50, Olympus). The levels of phagocytosis measured
for wild-type and DescN EHEC were equivalent for the 85-170
and EDL-933 EHEC strains.
All data were analysed by unpaired, two-tailed Student’s t-test,
and considered statistically signiﬁcant for P < 0.05.
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